U.S. Hospitality Stock News

BDX share performance and business snapshot Becton Dickinson (BDX) has drawn attention after a period in which the share price has declined about 16% over the past month and roughly 20% over the past 3 months. This has prompted closer scrutiny from investors. The company operates across several healthcare segments, including Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences, supplying devices and diagnostics used by hospitals, laboratories, and...

In March 2026, BBB Foods Inc. reported its fourth-quarter and full-year 2025 results, showing quarterly revenue of MX$21,972.48 million and a quarterly net loss of MX$1,042.51 million, alongside full-year revenue of MX$78,152.94 million and a full-year net loss of MX$2,839.57 million. While revenue increased year-on-year for both the quarter and full year, the company moved from full-year net income of MX$334.42 million to a substantial net loss, highlighting a sharp reversal in...

Why the Piketon data center project matters for AEP shares American Electric Power Company (AEP) is in focus after AEP Ohio, the U.S. Department of Energy and SB Energy outlined multi billion dollar transmission and digital infrastructure plans tied to a 10 gigawatt data center campus in Piketon, Ohio. See our latest analysis for American Electric Power Company. The Piketon announcement comes after a year where AEP’s recent 1 day share price return of 1.8% contrasts with a 7 day decline of...

In early February 2026, Hubbell reported Q4 2025 results showing revenue growth primarily driven by organic demand for its grid and infrastructure products, and analysts maintained a “Moderate Buy” consensus rating. This combination of strong underlying demand and generally supportive analyst views highlights how central grid and infrastructure exposure has become to Hubbell’s investment case. We’ll now examine how this stronger organic grid demand, highlighted in the Q4 results, may...

Wondering if Weatherford International at around US$91.55 is still offering value after a strong run, or if most of the upside is already reflected in the price. The stock shows a 5.5% gain over the last 7 days, a 13.2% return year to date, and a 72.7% return over 1 year, set against a 12.3% decline over the past month and a very large 5 year gain that is around 7x. These moves have kept attention on Weatherford International as investors weigh what the current share price implies for future...

For investors wondering whether CF Industries Holdings at around US$120 a share still offers value, or if most of the upside is already in the rear-view mirror, this article focuses squarely on what the current price might be giving you. The stock has seen a 23.7% gain over the last 30 days, 50.0% year to date, and 60.1% over 1 year. This naturally raises questions about how much of the story is already priced in and how much risk you are taking on at these levels. Recent news coverage has...

Event driven snapshot of NuScale Power NuScale Power (SMR) is back on many investors’ screens after recent share price volatility, with the stock closing at $11.70 and recent returns ranging from a 2.3% daily gain to a 38.0% 1 year decline. See our latest analysis for NuScale Power. That 2.3% 1 day share price gain comes after a series of weaker periods, with a 30 day share price return of 12.9% and a 1 year total shareholder return decline of 38.0%, even though the 3 year total shareholder...

Arcos Dorados Holdings Inc. recently approved a 2026 cash dividend totaling US$0.28 per share, to be paid in four equal quarterly installments of US$0.07 per share to Class A and Class B shareholders of record on specified dates throughout the year. At the same time, the company reported fourth-quarter 2025 results showing higher revenue but lower quarterly net income, alongside full-year 2025 revenue of US$4.68 billion and net income of US$212.12 million, highlighting a contrast between...

Earlier this month, BlackRock expanded its digital asset lineup by launching the iShares Staked Ethereum Trust ETF (ETHB), offering spot ether exposure with a staking component and a 0.25% sponsor fee, temporarily reduced to 0.12% on the first US$2.50 billion in assets under management for the first year. Alongside backing Securitize in the NYSE’s new tokenized equity platform and overseeing roughly US$130.00 billion across crypto-related products, BlackRock is deepening its role at the...

Redwire Corporation recently announced a US$12.8 million contract to deliver its Extensible Low-Profile Solar Array (ELSA) wings to Moog Inc., which will integrate them into its METEOR satellite bus for a Low Earth Orbit mission supporting an undisclosed national security customer. Beyond the immediate contract win, Moog’s decision to baseline Redwire’s ELSA wings as a standard METEOR bus component highlights potential for recurring national security and satellite power system demand. Next,...

DuPont de Nemours, Inc. recently announced it is seeking shareholder approval to amend its Certificate of Incorporation to permit a reverse stock split of its common stock at a ratio between 1-for-2 and 1-for-4, with the final ratio and timing left to the Board’s discretion and the ability to delay or abandon the move. This proposal introduces flexibility for DuPont to adjust its share count and share price structure in the future, which could influence how investors assess its capital...

Tempus AI (TEM) is back on investors’ radar after two cancer focused updates, a new collaboration on a pediatric acute myeloid leukemia registry, and fresh evidence supporting its genomic profiling capabilities. See our latest analysis for Tempus AI. Despite the positive sentiment around its pediatric leukemia registry and genomic profiling study, Tempus AI’s recent 30 day share price return of 15.81% and year to date share price return of 21.20% point to fading momentum, while the 1 year...

Stryker (NYSE:SYK) confirmed a cyberattack on its Microsoft environment that temporarily disrupted ordering, manufacturing, and shipping operations. The company reports the incident is now contained and manufacturing is being restored. Stryker states there is no evidence that customer or partner data was compromised. Stryker, trading at $332.59, is dealing with a material operational event that directly affected its core manufacturing and distribution processes. The stock has seen a 12.5%...

Open Text (NasdaqGS:OTEX) is back in focus after releasing a global GenAI security report with the Ponemon Institute, just ahead of its RSA Conference 2026 presentation featuring senior product and marketing leaders. See our latest analysis for Open Text. Despite the recent focus on GenAI security, Open Text’s 1-day and 7-day share price returns of 2.04% and 3.09% come after a 90-day share price return decline of 30.94% and a 1-year total shareholder return decline of 11.31%. This suggests...

Freeport-McMoRan has recently applied for environmental approval for a US$7.50 billion expansion of its El Abra copper mine in Chile, including new concentrator and desalination plants and additional tailings storage, with operations targeted to start in 2033 and significantly lift annual copper output if approved. At the same time, management is highlighting resilient copper demand from electrification and data centers and pointing to supportive government policy in both Chile and the US as...

Investors may be asking whether PPL at around US$36.90 offers good value today, or if the recent price leaves limited upside. The stock has seen mixed recent returns, with a 4.7% decline over the last 7 days and a 1.4% decline over the last 30 days, while still showing 5.1% year to date and 9.5% over 1 year. Over a longer stretch, PPL has returned 51.5% over 3 years and 52.8% over 5 years, which gives important context for anyone trying to understand how the current price fits into its...

Cogent Biosciences (COGT) is back in focus after the FDA accepted its New Drug Application for bezuclastinib in NonAdvanced Systemic Mastocytosis, setting a December 30, 2026 action date with no review issues flagged. See our latest analysis for Cogent Biosciences. The FDA milestone and mixed institutional trading have come at a time when Cogent’s share price has been volatile, with a 1 day share price return of 6.08% and a 90 day share price return of 11.85%. The 1 year total shareholder...

Wondering if Uber Technologies at US$75.12 is offering value right now, or if the share price already reflects what you might hope to get from it? The stock has returned 0.6% over the last week and 1.7% over the last month. The year-to-date return sits at a 9.3% decline, and the 1-year return at a 1.8% decline, alongside a very large 3-year gain and a 40.8% return over 5 years. These mixed returns have come as Uber remains a central player in ride hailing and delivery, with ongoing product...

Wondering if PBF Energy at around US$46.59 is offering value or asking you to pay up for past returns? This article breaks down what the current price really reflects. The stock has posted returns of 6.9% over the last 7 days, 35.5% over the last 30 days, 63.3% year to date and 146.4% over the past year, which naturally raises questions about what is already priced in. Recent news flow around US refiners has focused on supply and demand conditions in fuel markets, regulatory developments and...

How eBay Stock Has Been Moving Recently Without a single headline catalyst in focus, eBay (EBAY) has still given investors plenty to watch, from its recent share performance to the income and revenue figures backing the marketplace business. See our latest analysis for eBay. At a share price of $89.85, eBay’s recent 1 day share price return of 0.98% sits against a softer 7 day share price return decline of 4.02%. A 1 year total shareholder return of 37.43% and 3 year total shareholder return...

If you are wondering whether ImmunityBio's share price still offers value after a strong run, it helps to step back and look carefully at what the market is currently pricing in. The stock last closed at US$9.40, with returns of 14.5% over the past week, 8.0% over the past month, 365.3% year to date, 229.8% over one year and negative 61.9% over five years. This gives a mixed picture of recent momentum and longer term experience for shareholders. Recent headlines around ImmunityBio have...

Earlier this week, Meritage Homes was affected by concerns that sustained high US interest rates and geopolitical tensions with Iran could weigh on housing demand, as higher Treasury yields pushed mortgage rates to about 6.22% and the Federal Reserve signaled little urgency to cut its benchmark rate. This combination of elevated borrowing costs and geopolitical stress has sharpened investor focus on how sensitive homebuilders’ order volumes and profitability may be to protracted...

Kenvue (KVUE) has attracted attention after recent trading left the share price around $17.60, with a mixed pattern of returns over the past week, month, and past three months prompting fresh scrutiny from income and value focused investors. See our latest analysis for Kenvue. Recent trading has been choppy, with a 1 day share price return of 1.15%, but a 30 day share price return showing a 5.98% decline. The 1 year total shareholder return of a 21.45% decline underlines how sentiment has...

What Galaxy Digital’s recent trading performance tells you Galaxy Digital (GLXY) has drawn attention after a 4.73% gain over the past day, contrasting with a 7.66% decline over the past week and mixed returns over the month and past 3 months. See our latest analysis for Galaxy Digital. That 4.73% one day share price move comes after a 7.66% 7 day share price pullback and a 12.32% year to date share price decline, even though the 1 year total shareholder return is 66% and the 3 year total...